| 000 | 01706 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514223529.0 | ||
| 264 | 0 | _c20050727 | |
| 008 | 200507s 0 0 eng d | ||
| 022 | _a0091-3057 | ||
| 024 | 7 |
_a10.1016/j.pbb.2005.01.012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBubeníková, Vera | |
| 245 | 0 | 0 |
_aThe effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. _h[electronic resource] |
| 260 |
_bPharmacology, biochemistry, and behavior _cApr 2005 |
||
| 300 |
_a591-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcoustic Stimulation |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xpharmacology |
| 650 | 0 | 4 |
_aBenzodiazepines _xpharmacology |
| 650 | 0 | 4 |
_aClozapine _xpharmacology |
| 650 | 0 | 4 |
_aDibenzothiepins _xpharmacology |
| 650 | 0 | 4 |
_aDizocilpine Maleate _xantagonists & inhibitors |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2A _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xagonists |
| 650 | 0 | 4 |
_aReceptors, Muscarinic _xdrug effects |
| 650 | 0 | 4 |
_aReflex, Startle _xdrug effects |
| 650 | 0 | 4 |
_aRisperidone _xpharmacology |
| 700 | 1 | _aVotava, Martin | |
| 700 | 1 | _aHorácek, Jirí | |
| 700 | 1 | _aPálenícek, Tomás | |
| 700 | 1 | _aDockery, Colleen | |
| 773 | 0 |
_tPharmacology, biochemistry, and behavior _gvol. 80 _gno. 4 _gp. 591-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pbb.2005.01.012 _zAvailable from publisher's website |
| 999 |
_c15489674 _d15489674 |
||